Benazepril impurity profiling is essential for regulatory compliance and pharmaceutical development. These impurities—whether process-related, degradation products, or metabolites—must be structurally characterized and qualified under ICH and FDA guidelines. Their presence is monitored during synthesis, formulation, and stability testing.
We supply a full suite of Benazepril EP impurities, each validated to meet European Pharmacopoeia specifications. These compounds support method development, impurity quantification, and forced degradation studies. Nitrosamine impurities and glucuronide conjugates are also available for advanced toxicological assessments.
Our catalog includes Benazepril-related compounds such as stereoisomers, synthetic intermediates, and degradation products. These are critical for impurity identification, analytical method validation, and genotoxicity screening. All compounds are supplied with detailed analytical data and Certificates of Analysis.
Benazepril impurity reference standards are supplied with full structural characterization and validated analytical profiles. These standards are used in ANDA and DMF submissions, quality control, and pharmaceutical research. EP/USP traceable materials are available upon request, and all products meet global regulatory expectations.
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
